[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:decipher":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Decipher",6,5,[8,16,22,29,36,42],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06067269","Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial",[12],"Phase 2","RECRUITING","2026-08-26T02:16:57.705506Z","2026-05-05T02:43:29.699425Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06150417","MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)",[12],"2026-08-26T02:15:33.331531Z","2026-05-05T02:43:27.060381Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT03495427","PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w\u002F High Decipher Test Scores",[26],"Phase 2\u002FPhase 3","2026-08-26T02:17:02.694423Z","2026-05-05T02:43:28.016109Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT05852041","rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance",[33],"Early Phase 1","2026-08-26T02:18:32.765187Z","2026-05-05T02:43:27.415525Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07077239","Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity",[],"2026-08-26T02:19:23.493898Z","2026-05-13T02:55:06.651249Z",{"nct_id":43,"title":44,"phases":45,"status":46,"updated_at":47,"content_modified":48},"NCT04915508","Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T02:39:26.665235Z","2026-05-05T02:43:28.726756Z"]